Addressing the Unique Needs of Women with Migraine

Addressing the Unique Needs of Women with Migraine

CME/CE Broadcast Replay

Addressing the Unique Needs of Women with Migraine
RestartResume

Address women’s unique migraine needs head-on and enable patients to have better control of their migraines through acute and preventive strategies.

Available credits: 0.75

Time to complete: 45 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Women with migraine have unique needs that often remain undermanaged. Have you taken a critical look at the standard of care and how current treatment strategies have recently shifted? Groundbreaking research on the calcitonin gene-related peptide (CGRP) pathway has led to the development of new medications that act on the specific cascade of inflammatory response associated with migraine. Also called gepants, the CGRP receptor antagonists confer clinical benefit to patients who seek better control of their migraines.

    Tune in to this Women’s Health 2021 program to hear our experts, Drs. Peter Goadsby and Kathleen Mullin, discuss the diagnosis of migraine with a focus on the recent evolution of acute and preventive treatment strategies and the role of gepants. Are you doing all you can to ensure that your patients’ needs are optimally addressed? 

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:

    Peter Goadsby, MD, PhD, DSc
    Professor of Neurology
    David Geffen School of Medicine at UCLA
    Los Angeles, CA
    Consulting Fees: AEON Biopharma, Amgen, Allergan, Biohaven Pharmaceuticals Inc., Eli Lilly and Company, Epalex, GlaxoSmithKline, Impel NeuroPharma, Lundbeck, Novartis, Pfizer
    Research Grants: Amgen, Celgene, Eli Lilly and Company

    Kathleen Mullin, MD
    Associate Medical Director, Clinical Research
    New England Institute for Neurology and Headache
    Stamford, CT
    Consulting Fees: Biohaven Pharmaceuticals, Eli Lilly and Company 
    Speaker Bureau: Biohaven Pharmaceuticals, Eli Lilly and Company, Teva Pharmaceuticals

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Nick Lombardi has no relevant relationships to report.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Estelle Perera has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Identify the signs and symptoms of migraine needed to make an accurate and timely diagnosis
    • Discuss the safety and efficacy data for current therapeutic options for migraine prevention and acute treatment
    • Describe treatment strategies for women diagnosed with migraine at different stages of life
  • Target Audience

    This activity is designed to meet the educational needs of OBGYN clinicians (md/NPs/PAs/nurses) and primary care clinicians who manage women’s health. 

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 45 minutes of nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Biohaven Pharmaceuticals.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments

Register

We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free